Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized investigator-blinded intraindividual half-side comparison of Keto-Stulln UD versus Zaditen ophtha sine in seasonal allergic conjunctivitis
2005-003381-41Phase 3Completed
- Sponsor
- Pharma Stulln
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ketotifen hydrogen fumarate and ketotifen in seasonal allergic conjunctivitis (SAC), sponsored by Pharma Stulln. Started Nov 2006; status: completed.
02
Drugs
ketotifen hydrogen fumarateketotifen
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on 2005-003381-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003381-41.